Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination

Acta Oncologica

Volumn 50, Issue 8, 2011, Pages 1215-1219

  Du, Juan ^a   Näsman, Anders ^a   Carlson, Joseph W ^a   Ramqvist, Torbjörn ^a   Dalianis, Tina ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER IMMUNIZATION; DNA EXTRACTION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 73; MAJOR CLINICAL STUDY; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SWEDEN; UNIVERSITY HOSPITAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SWEDEN; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 80155195391     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.584556     Document Type: Article

References (25)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997;8:755-63.
3. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010;49:725-36.
4. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191-9.
5. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in fi ve continents. Volume VIII. IARC Sci Publ 2002;155:1-781.
6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
7. Castellsague X, de Sanjose S, Aguado T, Louie KS, Bruni L, Munoz J, et al. HPV and cervical cancer in the 2007 report. Vaccine 2007;25(Suppl 3):C1 - 230.
8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
9. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 2011;128:927-35.
10. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancerworldwide: A meta-analysis. Br J Cancer 2003;88:63-73.
11. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective crosssectional worldwide study. Lancet Oncol 2010;11:1048-56.
12. Usubutun A, Alemany L, Kucukali T, Ayhan A, Yuce K, de Sanjose S, et al. Human papillomavirus types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol 2009;28:541-8.
13. Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, et al. Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev 2010;19:2389-400.
14. Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, et al. Multi-site study of HPV type-specifi c prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Cancer 2010;103:209-16.
15. Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, et al. Human papillomavirus prevalence and type-specifi c relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer 2010;10:259.
16. Garland SM, Smith JS. Human papillomavirus vaccines: Current status and future prospects. Drugs 2010;70:1079-98.
17. Diaz ML. Prevention of cervical, vaginal, and vulval cancers: Role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine. Int J Womens Health 2010;1:119-29.
18. Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez- Avila M, Wheeler CM, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16 - 26 years. J Infect Dis 2009;199:926-35.
19. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classifi cation of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
20. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006;44:504-12.
21. Ramqvist T, Du J, Lunden M, Ahrlund-Richter S, Ferreira J, Marions L, et al. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15 - 23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis 2011;43:115-21.
22. Dahlstrom LA, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S, et al. Prospective study of human papillomavirusand risk of cervical adenocarcinoma. Int J Cancer 2010;127:1923-30.
23. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001;37:246-50.
24. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-3.
25. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viralinduced carcinoma? Int J Cancer 2009;125:362-6.